Literature DB >> 18953719

Maintenance of serological memory.

Jens Wrammert1, Rafi Ahmed.   

Abstract

Long-lived plasma cells are key to maintaining long-term humoral immunity after infection or vaccination. Some vaccines and/or infections induce antibody levels that remain stable for the life of the individual. However, the mechanism whereby these long-lived plasma cells are maintained over long periods of time remains an open question. Furthermore, given a finite number of sustainable plasma cells within the bone marrow, it is also unclear how space for newly induced plasma cells is generated without compromising the pre-existing repertoire. Here we review the current understanding of these important issues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18953719     DOI: 10.1515/bc.2008.066

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  17 in total

1.  HIV: Immune memory downloaded.

Authors:  Dennis R Burton; Pascal Poignard
Journal:  Nature       Date:  2009-04-02       Impact factor: 49.962

2.  Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.

Authors:  David A Garber; Leigh A O'Mara; Sailaja Gangadhara; Monica McQuoid; Xiugen Zhang; Rui Zheng; Kiran Gill; Meena Verma; Tianwei Yu; Brent Johnson; Bing Li; Cynthia A Derdeyn; Chris Ibegbu; John D Altman; Eric Hunter; Mark B Feinberg
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

3.  Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination.

Authors:  Dimitrios G Koutsonanos; Maria del Pilar Martin; Vladimir G Zarnitsyn; Joshy Jacob; Mark R Prausnitz; Richard W Compans; Ioanna Skountzou
Journal:  J Infect Dis       Date:  2011-06-17       Impact factor: 5.226

4.  HPV - immune response to infection and vaccination.

Authors:  Margaret Stanley
Journal:  Infect Agent Cancer       Date:  2010-10-20       Impact factor: 2.965

5.  Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies.

Authors:  Nicole A Doria-Rose; Rachel M Klein; Maura M Manion; Sijy O'Dell; Adhuna Phogat; Bimal Chakrabarti; Claire W Hallahan; Stephen A Migueles; Jens Wrammert; Rafi Ahmed; Martha Nason; Richard T Wyatt; John R Mascola; Mark Connors
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

6.  Memory B cells and pneumococcal antibody after splenectomy.

Authors:  Heather Wasserstrom; James Bussel; Lony C-L Lim; Charlotte Cunningham-Rundles
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

7.  Persistent infection contributes to heterologous protective immunity against fatal ehrlichiosis.

Authors:  Nagaraja R Thirumalapura; Emily C Crossley; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

Review 8.  Cellular and molecular mechanisms of memory T-cell survival.

Authors:  Andre Tanel; Simone G Fonseca; Bader Yassine-Diab; Rebeka Bordi; Joumana Zeidan; Yu Shi; Clarisse Benne; Rafick-Pierre Sékaly
Journal:  Expert Rev Vaccines       Date:  2009-03       Impact factor: 5.217

9.  Multi-therapeutic potential of autoantibodies induced by immune complexes trapped on follicular dendritic cells.

Authors:  Mohey Eldin El Shikh; Maciej Kmieciak; Masoud H Manjili; Andras K Szakal; Costantino Pitzalis; John G Tew
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

10.  Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.

Authors:  Marc C Levesque; M Anthony Moody; Kwan-Ki Hwang; Dawn J Marshall; John F Whitesides; Joshua D Amos; Thaddeus C Gurley; Sallie Allgood; Benjamin B Haynes; Nathan A Vandergrift; Steven Plonk; Daniel C Parker; Myron S Cohen; Georgia D Tomaras; Paul A Goepfert; George M Shaw; Jörn E Schmitz; Joseph J Eron; Nicholas J Shaheen; Charles B Hicks; Hua-Xin Liao; Martin Markowitz; Garnett Kelsoe; David M Margolis; Barton F Haynes
Journal:  PLoS Med       Date:  2009-07-07       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.